NCT ID | NCT02713529 |
Title | Safety Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | no |
Sponsors | Amgen |
Indications | |
Therapies | |
Age Groups: | adult |